|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 9/64 | |
| C07K 14/755 | |||
| C12N 9/96 | |||
| A61K 47/26 | |||
| C07K 14/535 |
| (11) | Number of the document | 2561070 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11717538.0 |
| Date of filing the European patent application | 2011-04-20 | |
| (97) | Date of publication of the European application | 2013-02-27 |
| (45) | Date of publication and mention of the grant of the patent | 2015-06-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2011/056326 |
| Date | 2011-04-20 |
| (87) | Number | WO 2011/131720 |
| Date | 2011-10-27 |
| (30) | Number | Date | Country code |
| 325975 P | 2010-04-20 | US | |
| 10160470 | 2010-04-20 | EP |
| (72) |
IVARSSON, Elsa, SE
KNUTSSON, Josefin, SE
RIPPNER, Brita, SE
NILSSON, Ulrika, SE
AGERKVIST, Irčne, SE
|
| (73) |
Octapharma AG,
Seidenstrasse 2, 8853 Lachen,
CH
|
| (54) | NEW STABILIZING AGENT FOR PHARMACEUTICAL PROTEINS |
| NEW STABILIZING AGENT FOR PHARMACEUTICAL PROTEINS |